Skip to main content
. 2012 Jan 11;29(4):607–612. doi: 10.3892/ijmm.2012.884

Figure 1.

Figure 1

Inhibitory effect of alpinetin on the growth of human pancreatic cancer cell lines. BxPC-3, PANC-1 and AsPC-1 cells were treated with different concentrations of alpinetin (0, 20, 40, 60 and 80 μg/ml) for 24, 48 and 72 h respectively. Cell proliferation was then determined by the MTT assay. The results are representative of six independent experiments.